Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Food Funct ; 6(6): 1847-54, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25940566

RESUMEN

Mango fruit contain many bioactive compounds, some of which are transcription factor regulators. Estrogen receptor alpha (ERα) and beta (ERß) are two regulators of gene transcription that are important in a variety of physiological processes and also in diseases including breast cancer. We examined the ability of the mango constituents quercetin, mangiferin, and the aglycone form of mangiferin, norathyriol, to activate both isoforms of the estrogen receptor. Quercetin and norathyriol decreased the viability of MCF-7 breast cancer cells whereas mangiferin had no effect on MCF-7 cells. We also determined that quercetin and mangiferin selectively activated ERα whereas norathyriol activated both ERα and ERß. Despite quercetin, mangiferin and norathyriol having similar polyphenolic structural motifs, only norathyriol activated ERß, showing that bioactive agents in mangoes have very specific biological effects. Such specificity may be important given the often-opposing roles of ERα and ERß in breast cancer proliferation and other cellular processes.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Receptor alfa de Estrógeno/agonistas , Fitoestrógenos/farmacología , Quercetina/farmacología , Xantenos/farmacología , Xantonas/farmacología , Animales , Antineoplásicos Fitogénicos/antagonistas & inhibidores , Antineoplásicos Fitogénicos/metabolismo , Neoplasias de la Mama/metabolismo , Células COS , Supervivencia Celular/efectos de los fármacos , Chlorocebus aethiops , Antagonistas del Receptor de Estrógeno/farmacología , Receptor alfa de Estrógeno/antagonistas & inhibidores , Receptor alfa de Estrógeno/genética , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/agonistas , Receptor beta de Estrógeno/antagonistas & inhibidores , Receptor beta de Estrógeno/genética , Receptor beta de Estrógeno/metabolismo , Femenino , Frutas/química , Genes Reporteros/efectos de los fármacos , Humanos , Células MCF-7 , Mangifera/química , Proteínas de Neoplasias/agonistas , Proteínas de Neoplasias/antagonistas & inhibidores , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Fitoestrógenos/antagonistas & inhibidores , Fitoestrógenos/metabolismo , Quercetina/antagonistas & inhibidores , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Elementos de Respuesta/efectos de los fármacos , Activación Transcripcional/efectos de los fármacos , Xantenos/antagonistas & inhibidores , Xantenos/metabolismo , Xantonas/antagonistas & inhibidores , Xantonas/metabolismo
2.
Food Chem ; 149: 253-63, 2014 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-24295704

RESUMEN

In this study we determined the qualitative composition and distribution of phytochemicals in peel and flesh of fruits from four different varieties of mango using mass spectrometry profiling following fractionation of methanol extracts by preparative HPLC. Gallic acid substituted compounds, of diverse core structure, were characteristic of the phytochemicals extracted using this approach. Other principal compounds identified were from the quercetin family, the hydrolysable tannins and fatty acids and their derivatives. This work provides additional information regarding mango fruit phytochemical composition and its potential contribution to human health and nutrition. Compounds present in mango peel and flesh are likely subject to genetic control and this will be the subject of future studies.


Asunto(s)
Mangifera/química , Fitoquímicos/química , Extractos Vegetales/química , Cromatografía Líquida de Alta Presión , Frutas/química , Frutas/clasificación , Mangifera/clasificación , Espectrometría de Masas , Fitoquímicos/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación
3.
Food Funct ; 4(3): 481-91, 2013 Feb 26.
Artículo en Inglés | MEDLINE | ID: mdl-23295454

RESUMEN

Plant phytochemicals are increasingly recognised as sources of bioactive molecules which may have potential benefit in many health conditions. In mangoes, peel extracts from different cultivars exhibit varying effects on adipogenesis in the 3T3-L1 adipocyte cell line. In this study, the effects of preparative HPLC fractions of methanol peel extracts from Irwin, Nam Doc Mai and Kensington Pride mangoes were evaluated. Fraction 1 contained the most hydrophilic components while subsequent fractions contained increasingly more hydrophobic components. High content imaging was used to assess mango peel fraction effects on lipid accumulation, nuclei count and nuclear area in differentiating 3T3-L1 cells. For all three mango cultivars, the more hydrophilic peel fractions 1-3 inhibited lipid accumulation with greater potency than the more hydrophobic peel fractions 4. For all three cultivars, the more lipophilic fraction 4 had concentrations that enhanced lipid accumulation greater than fractions 1-3 as assessed by lipid droplet integrated intensity. The potency of this fraction 4 varied significantly between cultivars. Using mass spectrometry, five long chain free fatty acids were detected in fraction 4; these were not present in any other peel extract fractions. Total levels varied between cultivars, with Irwin fraction 4 containing the highest levels of these free fatty acids. Lipophilic components appear to be responsible for the lipid accumulation promoting effects of some mango extracts and are the likely cause of the diverse effects of peel extracts from different mango cultivars on lipid accumulation.


Asunto(s)
Adipocitos/efectos de los fármacos , Metabolismo de los Lípidos/efectos de los fármacos , Mangifera/química , Extractos Vegetales/farmacología , Células 3T3-L1 , Adipocitos/metabolismo , Adipogénesis/efectos de los fármacos , Animales , Cromatografía Líquida de Alta Presión , Fibroblastos/citología , Fibroblastos/metabolismo , Frutas/química , Ratones
4.
Food Funct ; 3(8): 828-36, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22699857

RESUMEN

Obesity is associated with many chronic disease states, such as diabetes mellitus, coronary disease and certain cancers, including those of the breast and colon. There is a growing body of evidence that links phytochemicals with the inhibition of adipogenesis and protection against obesity. Mangoes (Mangifera indica L.) are tropical fruits that are rich in a diverse array of bioactive phytochemicals. In this study, methanol extracts of peel and flesh from three archetypal mango cultivars; Irwin, Nam Doc Mai and Kensington Pride, were assessed for their effects on a 3T3-L1 pre-adipocyte cell line model of adipogenesis. High content imaging was used to assess: lipid droplets per cell, lipid droplet area per cell, lipid droplet integrated intensity, nuclei count and nuclear area per cell. Mango flesh extracts from the three cultivars did not inhibit adipogenesis; peel extracts from both Irwin and Nam Doc Mai, however, did so with the Nam Doc Mai extract most potent at inhibiting adipogenesis. Peel extract from Kensington Pride promoted adipogenesis. The inhibition of adipogenesis by Irwin (100 µg mL(-1)) and Nam Doc Mai peel extracts (50 and 100 µg mL(-1)) was associated with an increase in the average nuclear area per cell; similar effects were seen with resveratrol, suggesting that these extracts may act through pathways similar to resveratrol. These results suggest that differences in the phytochemical composition between mango cultivars may influence their effectiveness in inhibiting adipogenesis, and points to mango fruit peel as a potential source of nutraceuticals.


Asunto(s)
Adipogénesis/efectos de los fármacos , Frutas/química , Mangifera/química , Extractos Vegetales/farmacología , Células 3T3-L1 , Adipocitos/efectos de los fármacos , Adipocitos/ultraestructura , Animales , Núcleo Celular/efectos de los fármacos , Núcleo Celular/ultraestructura , Ratones , Resveratrol , Especificidad de la Especie , Estilbenos/farmacología
5.
Mol Nutr Food Res ; 56(3): 357-87, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22147637

RESUMEN

The plant kingdom harbours many diverse bioactive molecules of pharmacological relevance. Temperate fruits and vegetables have been highly studied in this regard, but there have been fewer studies of fruits and vegetables from the tropics. As global consumers demand and are prepared to pay for new appealing and exotic foods, tropical fruits are now being more intensively investigated. Polyphenols and major classes of compounds like flavonoids or carotenoids are ubiquitously present in these fruits, as they are in the temperate ones, but particular classes of compounds are unique to tropical fruits and other plant parts. Bioactivity studies of compounds specific to tropical fruit plants may lead to new drug discoveries, while the synergistic action of the wide range of diverse compounds contained in plant extracts underlies nutritional and health properties of tropical fruits and vegetables. The evidence for in vitro and animal bioactivities is a strong indicator of the pharmacological promise shown in tropical fruit plant biodiversity. In this review, we will discuss both the occurrence of potential bioactive compounds isolated and identified from a selection of tropical fruit plants of importance in Australia, as well as recent studies of bioactivity associated with such fruits and other fruit plant parts.


Asunto(s)
Frutas/química , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Verduras/química , Australia , Biodiversidad , Carotenoides/aislamiento & purificación , Flavonoides/aislamiento & purificación , Polifenoles/aislamiento & purificación , Clima Tropical
6.
J Food Sci ; 76(1): H11-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21535682

RESUMEN

Mangos are a source of bioactive compounds with potential health promoting activity. Biological activities associated with mango fractions were assessed in cell-based assays to develop effective extraction and fractionation methodologies and to define sources of variability. Two techniques were developed for extraction and fractionation of mango fruit peel and flesh. Liquid chromatography-mass spectrometry (LC-MS) was used to assess compositional differences between mango fractions in flesh extracts. Many of the extracts were effective in inhibiting the proliferation of human breast cancer cells in vitro. All fractions showed bioactivity in PPAR activation assays, but quantitative responses showed marked fruit-to-fruit variability, highlighting the need to bulk fruit prior to extraction for activity-guided fractionation of bioactive components. This study also suggests that combinations of diverse molecular components may be responsible for cell-level bioactivities from mango fractions, and that purification and activity profiling of individual components may be difficult to relate to whole fruit effects. Practical Application: Although the health benefits of fruits are strongly indicated from studies of diet and disease, it is not known what role individual fruit types can play, particularly for tropical fruits. This study shows that there is a diversity of potentially beneficial bioactivities within the flesh and peel of mango fruit, although fruit-to-fruit variation can be large. The results add to the evidence that the food approach of eating all components of fruits is likely to be more beneficial to health than consuming refined extracts, as the purification process would inevitably remove components with beneficial bioactivities.


Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Proliferación Celular/efectos de los fármacos , Frutas/química , Mangifera/química , PPAR gamma/metabolismo , Extractos Vegetales/farmacología , Animales , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/aislamiento & purificación , Neoplasias de la Mama/metabolismo , Células COS , Fraccionamiento Químico , Chlorocebus aethiops , Cromatografía Líquida de Alta Presión , Femenino , Genes Reporteros/efectos de los fármacos , Humanos , PPAR gamma/genética , Fitoterapia , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Poligalacturonasa/metabolismo , Reproducibilidad de los Resultados , Espectrometría de Masa por Ionización de Electrospray , Activación Transcripcional/efectos de los fármacos
7.
J Agric Food Chem ; 58(8): 5181-6, 2010 Apr 28.
Artículo en Inglés | MEDLINE | ID: mdl-20349963

RESUMEN

This study tested the hypothesis that mango extracts contain bioactive molecules capable of modulating endothelial cell migration, an essential step in the formation of new blood vessels or angiogenesis. The formation of new blood vessels is an important therapeutic target for diseases such as limb ischemia, coronary infarction or stroke. We examined the effect of mango peel and flesh extracts as well as the individual polyphenolic molecules, mangiferin and quercetin, on bovine aortic cell migration using a modified Boyden chamber assay. Our results show that mangiferin, and extracts rich in mangiferin, increase endothelial cell migration. The dose-effect relationship for various extracts further suggests that this action of mangiferin is modulated by other components present in the extracts. The promigratory effect of mango extracts or mangiferin was unrelated to an effect on cell proliferation, and did not involve a change in the production of matrix metalloprotease-2 or -9 by the endothelial cells. Taken together, these results suggest that mangiferin present in mango extracts may have health promoting effects in diseases related to the impaired formation of new blood vessels.


Asunto(s)
Movimiento Celular/efectos de los fármacos , Endotelio Vascular/efectos de los fármacos , Mangifera/química , Neovascularización Fisiológica/efectos de los fármacos , Extractos Vegetales/farmacología , Xantonas/farmacología , Animales , Bovinos , Células Cultivadas , Cromatografía Líquida de Alta Presión , Endotelio Vascular/citología , Espectrometría de Masas en Tándem
8.
J Pharmacol Toxicol Methods ; 49(2): 81-7, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-14990332

RESUMEN

INTRODUCTION: Fluorescence microplate readers for the measurement of cytosolic free Ca(2+) ([Ca(2+)](i)) are used as a drug screening tool, particularly for immortal cell lines. However, wider application of this methodological approach to more differentiated cells such as neurons would also be useful for the screening of compounds that modulate synaptic transmission. Such an approach has the potential to identify lead compounds for the development of novel drugs for the treatment of epilepsy, pathological pain states, Parkinson's disease, or other neurological disorders. METHODS: In this paper, we describe the development of a microplate reader assay for the assessment of [Ca(2+)](i) in a primary culture of rat hippocampal neurons maintained in Neurobasal medium using the fluorescent calcium indicator, fluo-3. RESULTS: The assay was appropriate for the screening of glutamate receptor agonists and antagonists. Furthermore, lowering the extracellular Mg(2+) concentration ([Mg(2+)](O)) produced consistent oscillations in neuronal [Ca(2+)](i) detected using the fluorescence microplate reader. These oscillations were inhibited by the GABA(B) agonist, baclofen, and the NMDA receptor antagonist, LY274614. DISCUSSION: Our results indicate that assessment of the inhibitory effects of agents on spontaneous [Ca(2+)](i) oscillations in neurons may be useful for the identification of agents that act on targets for which specific screening methods are not currently available, or those which act via a previously unknown pathway to inhibit synaptic transmission. This technique also has the potential to increase the productivity of experiments designed to characterize changes in [Ca(2+)](i) (including calcium oscillations) in cultured neurons.


Asunto(s)
Calcio/metabolismo , Hipocampo/metabolismo , Neuronas/metabolismo , Espectrometría de Fluorescencia/instrumentación , Espectrometría de Fluorescencia/métodos , Compuestos de Anilina/metabolismo , Animales , Baclofeno/farmacología , Señalización del Calcio/efectos de los fármacos , Células Cultivadas , Evaluación Preclínica de Medicamentos/métodos , Feto/citología , Feto/embriología , Antagonistas del GABA/farmacología , Hipocampo/efectos de los fármacos , Hipocampo/embriología , Líquido Intracelular/efectos de los fármacos , Líquido Intracelular/metabolismo , Isoquinolinas/farmacología , Neuronas/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Receptores de N-Metil-D-Aspartato/antagonistas & inhibidores , Xantenos/metabolismo
9.
Anesth Analg ; 97(2): 494-505, 2003 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-12873944

RESUMEN

UNLABELLED: Indirect evidence indicates that morphine-3-glucuronide (M3G) may contribute significantly to the neuro-excitatory side effects (myoclonus and allodynia) of large-dose systemic morphine. To gain insight into the mechanism underlying M3G's excitatory behaviors, we used fluo-3 fluorescence digital imaging techniques to assess the acute effects of M3G (5-500 microM) on the cytosolic calcium concentration ([Ca(2+)](CYT)) in cultured embryonic hippocampal neurones. Acute (3 min) exposure of neurones to M3G evoked [Ca(2+)](CYT) transients that were typically either (a) transient oscillatory responses characterized by a rapid increase in [Ca(2+)](CYT) oscillation amplitude that was sustained for at least approximately 30 s or (b) a sustained increase in [Ca(2+)](CYT) that slowly recovered to baseline. Naloxone-pretreatment decreased the proportion of M3G-responsive neurones by 10%-25%, implicating a predominantly non-opioidergic mechanism. Although the naloxone-insensitive M3G-induced increases in [Ca(2+)](CYT) were completely blocked by N-methyl-D-aspartic acid (NMDA) antagonists and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate antagonist), CNQX did not block the large increase in [Ca(2+)](CYT) evoked by NMDA (as expected), confirming that M3G indirectly activates the NMDA receptor. Additionally, tetrodotoxin (Na(+) channel blocker), baclofen (gamma-aminobutyric acid(B) agonist), MVIIC (P/Q-type calcium channel blocker), and nifedipine (L-type calcium channel blocker) all abolished M3G-induced increases in [Ca(2+)](CYT), suggesting that M3G may produce its neuro-excitatory effects by modulating neurotransmitter release. However, additional characterization is required. IMPLICATIONS: Large systemic doses of morphine administered to some patients for cancer pain management have been reported to produce myoclonus and allodynia. Indirect evidence implicates the major morphine metabolite, morphine-3-glucuronide (M3G), in these neuro-excitatory side effects. Hence, this study was designed to gain insight into the cellular mechanism responsible for M3G's neuro-excitatory actions.


Asunto(s)
Estimulantes del Sistema Nervioso Central/farmacología , Hipocampo/metabolismo , Derivados de la Morfina/farmacología , Neuronas/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , 6-Ciano 7-nitroquinoxalina 2,3-diona/farmacología , Compuestos de Anilina , Animales , Baclofeno/farmacología , Calcio/metabolismo , Bloqueadores de los Canales de Calcio/farmacología , Células Cultivadas , Citosol/metabolismo , Antagonistas de Aminoácidos Excitadores/farmacología , Colorantes Fluorescentes , Agonistas del GABA/farmacología , Hipocampo/efectos de los fármacos , Procesamiento de Imagen Asistido por Computador , Inmunohistoquímica , Microscopía Fluorescente , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Neuronas/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Tetrodotoxina/farmacología , Xantenos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA